Arvind leads the Commercial Insights & Analytics (I&A) group at Regeneron, a leading biotechnology company that invents life-transforming medicines for people with serious diseases. In this capacity, he oversees the implementation of deep insight frameworks and analytics/data science capabilities to help bring the power of science and new medicines to patients who need them. A primary focus of the I&A group is to help realize Regeneron’s mission to do well by doing good. Prior to Regeneron, Arvind also spent time at Sanofi, Johnson & Johnson, BristolMyers Squibb, and Pfizer, focusing on the early pipeline and launch side of the business. During his tenure at these companies, he participated in several industry-leading pharma brand launches, spanning diverse therapeutic areas. Arvind’s interests include exploring new capabilities to enrich the understanding of customer behavior, engagement, and experience in omnichannel business ecosystems, as well as staying actively engaged in the evolution and application of machine intelligence and AI in augmenting data-driven decision-making. Arvind is a recipient of the 2023 AI100 Award in the Early AI Adopter category in recognition of his achievements to advance the field of Analytics & AI in organizations. Arvind earned his MBA from the Owen Graduate School of Management at Vanderbilt University. He also attained the Award of Achievement in Digital Analytics degree from the University of British Columbia (in association with the Digital Analytics Association) as well as a Certification in Data Science at the University of California, Irvine (in association with Predictive Analytics World). He is a former Associate in the Applied Analytics Capstone program at Columbia University, and a member of the Design Thinking Advisory Board at Rutgers University. Arvind is a past President of the Pharmaceutical Management Science Association (PMSA) and a member of the AIM Leaders Counci